Literature DB >> 8431910

Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype.

A M Meloni1, R M Dobbs, J E Pontes, A A Sandberg.   

Abstract

We report a consistent t(X;1)(p11.2;q21) that was observed in four cases of papillary renal tumors. In one of the cases, two cells showed the cytogenetic abnormality as the only change, whereas the other cases showed additional chromosomal anomalies particularly involving chromosomes 7 and 17. One identical t(X;1) has been reported previously in a papillary renal cell carcinoma. To date, all of the patients carrying this translocation have been males.

Entities:  

Mesh：

Year:  1993        PMID： 8431910     DOI： 10.1016/0165-4608(93)90050-v

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  19 in total

1.  A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation.

Authors:  P Argani; A Hawkins; C A Griffin; J D Goldstein; M Haas; J B Beckwith; C B Mankinen; E J Perlman
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

2.  Molecular pathology of renal cell carcinoma.

Authors:  S Störkel
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

3.  Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.

Authors:  M A Weterman; M Wilbrink; A Geurts van Kessel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

4.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

5.  PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.

Authors:  Ali Mirza Onder; Uygar Teomete; Pedram Argani; Stuart Toledano; Gaston Zilleruelo; Maria M Rodriguez
Journal:  Pediatr Nephrol       Date:  2006-06-29       Impact factor: 3.714

6.  Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.

Authors:  M A Weterman; J J van Groningen; L Tertoolen; A G van Kessel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 7.  Activators of G protein signaling in the kidney.

Authors:  Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2015-01-27       Impact factor: 4.030

Review 8.  Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Authors:  Eric C Kauffman; Christopher J Ricketts; Soroush Rais-Bahrami; Youfeng Yang; Maria J Merino; Donald P Bottaro; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2014-07-22       Impact factor: 14.432

9.  Localization of X chromosome short arm markers relative to synovial sarcoma- and renal adenocarcinoma-associated translocation breakpoints.

Authors:  R J Sinke; B de Leeuw; H A Janssen; D O Weghuis; R F Suijkerbuijk; A M Meloni; S Gilgenkrantz; W Berger; H H Ropers; A A Sandberg
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

Review 10.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.